13F Pro Quality Score

24.2/100

Rank #2,591 of 2,879 stocks

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

33.2/100

Profitability

13.9/100

Balance Sheet

9.2/100

Earnings Quality

30.0/100

Free Cash Flow

14.2/100

Institutional Flow

96.2/100

Revenue Scale

26.9/100

Dilution Risk

18.5/100

AMWL Stock Analysis & AI Quality Score

AI stock analysis and institutional research for American Well Corp (AMWL), a Industrials sector company. 13F Pro's AI-powered ranking engine scores AMWL at 24.2/100 on a 32-signal composite quality model, placing it at rank #2,591 of 2,879 stocks — the bottom half of the AI-ranked universe. AMWL scores in the top quartile across institutional flow (96.2). Areas of concern include balance sheet strength (9.2) and profitability (13.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 18.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), American Well Corp reports quarterly revenue of $54.9M, net income of $-10.9M, an operating margin of -31.8%. Top institutional holders of AMWL by reported 13-F value include MORGAN STANLEY, Senvest Management,, Cable Car Capital,, based on the most recent SEC filings. AMWL trades on the NYSE exchange and files with the SEC under CIK 1393584. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMWL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for American Well Corp directly from SEC EDGAR. American Well Corp's 13F Pro composite quality score has ranged between 15 and 46 since 2021, currently 24.2 — a declining long-term trajectory across 30 quarterly and live scoring snapshots.

Fun facts about American Well Corp

Quirks, history, and lore behind AMWL — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. healthcare technology company · listed on the NYSE · headquartered in Boston, Massachusetts · operates in the digital health space.
  • 2
    The Numbers
    A small-cap company with annual revenue in the low hundreds of millions of dollars — it has spent years investing heavily in growth while operating at a loss.
  • 3
    The History
    Founded in the early 2000s, it was a pioneer in connecting patients and doctors over video long before a global pandemic made that feel urgent.
  • 4
    The Secret
    Its platform powers telehealth visits for major health systems and insurers behind the scenes — most patients have no idea whose software they're using.
  • 5
    The Lore
    When COVID-19 hit in 2020, the stock soared as the world suddenly needed exactly what this company had been quietly building for nearly two decades.
  • 6
    The Giveaway
    Its ticker spells out a friendly "AMWL" and its name is practically a portmanteau of "American" and "Well" — as in, see a doctor and stay that way.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$54.9M

Net Income

Q1 2026

$-10.9M

Free Cash Flow

Q1 2026

$-988.0K

Operating Margin

Q1 2026

-31.8%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-2.0% YoY
$249.3MFY 2025
FY21 $252.8MFY23 $259.0MFY24 $254.4MFY25 $249.3M

Net Income

+54.0% YoY
$-95.7MFY 2025
FY21 $-176.3MFY23 $-675.2MFY24 $-208.1MFY25 $-95.7M

Operating Income

+51.6% YoY
$-105.3MFY 2025
FY21 $-179.1MFY23 $-692.1MFY24 $-217.5MFY25 $-105.3M

EPS (Diluted)

+57.1% YoY
$-5.96FY 2025
FY21 $-0.69FY23 $-2.38FY24 $-13.88FY25 $-5.96

Total Assets

-25.7% YoY
$323.8MFY 2025
FY21 $1.45BFY23 $589.7MFY24 $436.0MFY25 $323.8M

Op. Cash Flow

+48.2% YoY
$-66.0MFY 2025
FY21 $-141.5MFY23 $-148.3MFY24 $-127.3MFY25 $-66.0M

AI Insight: AMWL Financial Trends

AMWL's losses are narrowing sharply — Q1 2026 operating loss hit its best level at -$17M — but revenue has stalled at $55M for three straight quarters.

Operating loss improved dramatically from -$52M in Q2 2024 to -$17M in Q1 2026, a 67% reduction over six quarters.

Operating cash burn nearly eliminated: OCF improved from -$32M in Q3 2024 to -$1M in Q1 2026.

Revenue contracted from a $71M peak in Q2 2025 to $55M in Q1 2026, a three-quarter streak of stagnation or decline.

Equity has eroded steadily from $364M in Q2 2024 to $227M in Q1 2026, a $137M drawdown over eight quarters.

Revenue at $55M for three consecutive quarters signals potential demand ceiling; any further decline would be a critical warning.

Equity declining each quarter toward zero while losses persist raises long-term solvency concerns absent new capital.

OCF near breakeven at -$1M in Q1 2026 — watch whether this inflects positive, validating the loss-reduction story.

AI Insight: AMWL Ratio Trends

AMWL's operating losses are narrowing sharply — Q1 2026 OpMargin of -31.8% is the best single-quarter reading since the table begins, though profitability remains distant.

Operating margin improved from -83.4% in Q2 2024 to -31.8% in Q1 2026, a ~52pp reduction in losses over seven quarters.

ROA recovered from -39.3% in Q2 2024 to -13.4% in Q1 2026, signaling meaningfully better asset utilization.

Q3 2025 saw a sharp reversal — OpMargin deteriorated to -52.1% from -28.7% in Q2 2025, highlighting volatile quarter-to-quarter execution.

D/E data is entirely absent across all periods, leaving balance sheet leverage assessment impossible.

The Q3 2025 setback (-52.1% OpMargin) after Q2 2025's best reading (-28.7%) raises questions about whether improvement is durable.

ROIC remains deeply negative at -30.7% in Q1 2026; capital destruction persists despite the improving trend.

TTM OpMargin of -38.9% lags Q1 2026's -31.8%, suggesting recent quarters are better than the trailing average — momentum to confirm.

Get alerted when AMWL's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for American Well Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of AMWL

Put AMWL on your watchlist

Track score changes the day American Well Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AMWL a good stock to buy?

13F Pro's AI-powered analysis of American Well Corp (AMWL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMWL are available on the AMWL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AMWL?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMWL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of American Well Corp's investment landscape.